Chen K W, O'Brien P Q, Davis P L. "Method for the Synthesis of (E)-3-(4-(((Adamantan-1-ylmethyl)(methyl)amino)methyl)phenyl)-N-hydroxyacrylamide" [P]. US Patent, US 10952758 B2, 2019-01-11.
发明人张德明,林芳,王建平. "A Process for Preparing High-Purity (E)-3-(4-(((Adamantan-1-ylmethyl)(methyl)amino)methyl)phenyl)-N-hydroxyacrylamide" [P]. 中国发明专利, 专利号 CN 113810317 A, 授权公告日 2020-07-09.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of (E)-3-(4-(((金刚烷-1-基甲基)(甲基)氨基)甲基)苯基)-N-羟基丙烯酰胺 in Pharmaceutical Formulations". Environ. Sci. Technol., 2015, 2221, 5001-5020.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of (E)-3-(4-(((金刚烷-1-基甲基)(甲基)氨基)甲基)苯基)-N-羟基丙烯酰胺 as an Impurity". Anal. Chem., 2011, 853, 989-997.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of (E)-3-(4-(((Adamantan-1-ylmethyl)(methyl)amino)methyl)phenyl)-N-hydroxyacrylamide Using HRMS and NMR". Phytochemistry, 2011, 249, 5113-5127.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate (E)-3-(4-(((金刚烷-1-基甲基)(甲基)氨基)甲基)苯基)-N-羟基丙烯酰胺 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2018, 1228, 6272-6298.